Craniospinal Irradiation With Spinal IMRT to Improve Target Homogeneity
Creators
- 1. Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD (United States)
- 2. Memorial Regional Cancer Center, Radiation Oncology, Hollywood, FL (United States)
- 3. Division of Neurology and Pediatrics, Children's National Medical Center, Departments of Neurology and Pediatrics, George Washington University, Washington, D.C. (United States)
Description
Purpose: To report a new technique for the spinal component of craniospinal irradiation (CSI) in the supine position, to describe a verification procedure for this method, and to compare this technique with conventional plans. Methods and Materials: Twelve patients were treated between 1998 and 2006 with CSI using a novel technique. Sixteen children were treated with a conventional field arrangement. All patients were followed for outcomes and toxicity. CSI was delivered using a posteroanterior (PA) intensity-modulated radiation therapy (IMRT) spinal field matched to conventional, opposed lateral cranial fields. Treatment plans were generated for each patient using the IMRT technique and a standard PA field technique. The resulting dosimetry was compared to determine target homogeneity, maximum dose to normal tissues, and total monitor units delivered. Results: Evaluation of the spinal IMRT technique compared with a standard PA technique reveals a 7% reduction in the target volume receiving ≥110% of the prescribed dose and an 8% increase in the target volume receiving ≥95% of the prescribed dose. Although target homogeneity was improved, the maximum dose delivered in the paraspinal muscles was increased by approximately 8.5% with spinal IMRT compared to the PA technique. Follow-up evaluations revealed no unexpected toxicity associated with the IMRT technique. Conclusions: A new technique of spine IMRT is presented in combination with a quality assurance method. This method improves target dose uniformity compared to the conventional CSI technique. Longer follow-up will be required to determine any benefit with regard to toxicity and disease control
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2007.02.037;
- PII
- S0360-3016(07)00503-2;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 68
- Journal Issue
- 5
- Journal Page Range
- p. 1402-1409
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 38104875
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHILDREN; DOSIMETRY; IRRADIATION; MUSCLES; PATIENTS; PEDIATRICS; QUALITY ASSURANCE; RADIATION DOSES; RADIOTHERAPY; TOXICITY; VERIFICATION; VERTEBRAE
- Descriptors DEC
- AGE GROUPS; ANIMALS; BODY; DOSES; MAMMALS; MAN; MEDICINE; NUCLEAR MEDICINE; ORGANS; PRIMATES; RADIOLOGY; SKELETON; THERAPY; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.